Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RARA | P10276 | 1/20 | 0.39 |
| ▸ | RARB | P10826 | 1/20 | 0.39 |
| ▸ | RARG | P13631 | 1/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29386379 | 0.92 | KDM4E (0.44) | KDM4EMAPK1MAPTNPSR1TRPV1 | |
| SCHEMBL347184 | 0.92 | KDM4E (0.44) | KDM4EMAPK1MAPTNPSR1TRPV1 | |
| SCHEMBL4801925 | 0.92 | KDM4E (0.46) | KDM4EMAPK1MAPTNPSR1TRPV1 | |
| SCHEMBL14097237 | 0.91 | KDM4E (0.48) | KDM4EMAPK1MAPTNPSR1TRPV1 | |
| SCHEMBL12139610 | 0.89 | S1PR1 (0.44) | KDM4EMAPK1MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL31074354 | 0.87 | SMN1; SMN2 (0.40) | KDM4EMAPK1MAPTNPSR1TRPV1 | |
| SCHEMBL25791644 | 0.86 | KDM4E (0.44) | KDM4EMAPK1MAPTNPSR1GAA | |
| SCHEMBL11357426 | 0.86 | KDM4E (0.50) | KDM4EMAPK1MAPTNPSR1GAA | |
| SCHEMBL17708050 | 0.84 | KDM4E (0.66) | KDM4EMAPK1MAPTNPSR1SMN1; SMN2 | |
| SCHEMBL986849 | 0.84 | KDM4E (0.49) | KDM4EMAPK1MAPTNPSR1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6174503-B1 | NUCLEAR WASTES TREATMENT, ESPECIALLY WASTES WITH A HIGH CONCENTRATION OF COMPETING ALKALI METAL CATIONS | LOCKHEED MARTIN ENERGY RESEARCH CORPORATION | 2001-01-16 | — | — | US | claimed |
| WO-1999012878-A1 | SOLVENT AND PROCESS FOR EXTRACTING CESIUM FROM ALKALINE WASTE SOLUTIONS | LOCKHEED MARTIN ENERGY RES COR (US) | 1999-03-18 | — | — | WO | claimed |
| US-20260078407-A1 | RAAV Vectors for the Treatment of GM1 and GM2 Gangliosidosis | UNIV MASSACHUSETTS (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4612290-A1 | METHODS AND KITS FOR ISOLATING TARGET NUCLEIC ACIDS BELOW A TARGET SIZE FROM A SAMPLE | Phase Scientific International, Ltd. (HK) | 2025-09-10 | — | — | EP | disclosed |
| EP-4612288-A1 | METHODS FOR ISOLATING TARGET ANALYTES FROM BIOLOGICAL SAMPLES USING ATPS AND SOLID PHASE MEDIA | Phase Scientific International, Ltd. (HK) | 2025-09-10 | — | — | EP | disclosed |
| EP-4612289-A1 | METHODS, COMPOSITIONS AND KITS FOR CONCENTRATING TARGET ANALYTES FROM A BULK FLUID SAMPLE | Phase Scientific International, Ltd. (HK) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024213654-A1 | GENTLE METHOD FOR PRODUCING TRANSPARENT BIOLOGICAL PREPARATIONS FOR EXAMINATION BY LIGHT MICROSCOPY | GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS (UNIVERSITÄTSMEDIZIN) (DE) | 2024-10-17 | — | — | WO | disclosed |
| WO-2024093522-A1 | METHODS, COMPOSITIONS AND KITS FOR CONCENTRATING TARGET ANALYTES FROM A BULK FLUID SAMPLE | Phase Scientific International, Ltd. (CN) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024093519-A1 | METHODS FOR ISOLATING TARGET ANALYTES FROM BIOLOGICAL SAMPLES USING ATPS AND SOLID PHASE MEDIA | Phase Scientific International, Ltd. (CN) | 2024-05-10 | — | — | WO | disclosed |
| US-20240019420-A1 | METHODS AND COMPOSITIONS FOR ISOLATION AND RAPID DETECTION OF MICRO-ORGANISMS FROM BLOOD AND BODILY FLUIDS | ACUTIS DIAGNOSTICS, INC. (US) | 2024-01-18 | — | — | US | disclosed |
| US-20240011012-A1 | METHODS AND COMPOSITIONS FOR INHIBITING EXCESS NUCLEIC ACID PRECIPITATION | PFIZER (US) | 2024-01-11 | — | — | US | disclosed |
| US-20230390463-A1 | TISSUE SCAFFOLDS | JD BIOMEDICAL SOLUTIONS LTD (GB) | 2023-12-07 | — | — | US | disclosed |
| CN-116867902-A | Methods and compositions for inhibiting precipitation of excess nucleic acid | 辉瑞公司 | 2023-10-10 | — | — | CN | disclosed |
| US-20130187095-A1 | THERMOSETTING ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| US-20130187095-A1 | THERMOSETTING ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| US-20130187095-A1 | THERMOSETTING ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| US-6174503-B1 | NUCLEAR WASTES TREATMENT, ESPECIALLY WASTES WITH A HIGH CONCENTRATION OF COMPETING ALKALI METAL CATIONS | LOCKHEED MARTIN ENERGY RESEARCH CORPORATION | 2001-01-16 | — | — | US | disclosed |
| WO-1999012878-A1 | SOLVENT AND PROCESS FOR EXTRACTING CESIUM FROM ALKALINE WASTE SOLUTIONS | LOCKHEED MARTIN ENERGY RES COR (US) | 1999-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078407-A1 | RAAV Vectors for the Treatment of GM1 and GM2 Gangliosidosis | GALC, HEXB, MAN2B1 | KDM4E 1721/4885MAPK1 3158/4885MAPT 1899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.